To elucidate whether YF-18 exerts its anticancer activity through down-regulating Skp2 in lung cancer cells, A549-luciferase cells were transfected with Skp2 plasmid or empty vector as control and treated with YF-18 or not for further experiments. This evidence concerns the gene SKP2 and lung carcinoma.